Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.

Схожие документы

• Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
  по: Taylor, D N, et al.
  Опубликовано: (1993)
• Safety and Immunogenicity of Improved Shigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel
  по: Passwell, Justen H., et al.
  Опубликовано: (2001)
• Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
  по: Chu, C Y, et al.
  Опубликовано: (1991)
• Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
  по: Cohen, D, et al.
  Опубликовано: (1996)
• Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates
  по: Robbins, John B., et al.
  Опубликовано: (2009)